Mesoblast (MEOBF) Debt to Equity (2018 - 2022)

Mesoblast (MEOBF) has disclosed Debt to Equity for 5 consecutive years, with $0.19 as the latest value for Q2 2022.

  • Quarterly Debt to Equity rose 19.94% to $0.19 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $0.19 through Jun 2022, up 19.94% year-over-year, with the annual reading at $0.19 for FY2022, 19.94% up from the prior year.
  • Debt to Equity hit $0.19 in Q2 2022 for Mesoblast, up from $0.16 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.19 in Q2 2022 to a low of $0.16 in Q2 2021.
  • Historically, Debt to Equity has averaged $0.17 across 5 years, with a median of $0.17 in 2018.
  • Biggest five-year swings in Debt to Equity: fell 3.6% in 2020 and later grew 19.94% in 2022.
  • Year by year, Debt to Equity stood at $0.17 in 2018, then grew by 0.98% to $0.17 in 2019, then dropped by 3.6% to $0.16 in 2020, then decreased by 0.48% to $0.16 in 2021, then grew by 19.94% to $0.19 in 2022.
  • Business Quant data shows Debt to Equity for MEOBF at $0.19 in Q2 2022, $0.16 in Q2 2021, and $0.16 in Q2 2020.